Oncology Archive

A building with a stone facade displays a sign that reads
Nicole Dafoe, M.S.N., A.P.R.N., F.N.P.-C
A building with a stone facade displays a sign that reads
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
A building with a stone facade displays a sign that reads
Phase 2 Randomized Open-label Multicenter Study of Combination of ONC-392 and Pembrolizumab for the Treatment of Patients With Platinum Resistant Ovarian Cancer (PROC)
A building with a stone facade displays a sign that reads
A Phase 1/2, Dose Escalation and Expansion Trial to Evaluate the Safety and Efficacy of Tegavivint in Patients with Metastatic Colorectal Carcinoma
A building with a stone facade displays a sign that reads
An Open-Label Phase 1 Dose-Escalation and Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of PRTH-101 Alone or in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
A building with a stone facade displays a sign that reads
A Phase 2, Single-Arm Trial of Relacorilant in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (TRIDENT)
A building with a stone facade displays a sign that reads
A Phase 1, First-in-Human Study of the SMARCA2 Degrader, PLX-61639, in Patients With SMARCA4-Mutated Locally Advanced or Metastatic Solid Tumors
A building with a stone facade displays a sign that reads
Natera/Yanuvia_SCORE_Moorthy
International team led by HonorHealth Research Institute and U of A develop 3D chip platform for laboratory testing in cancer research
Cody Patten